Nugenic Pharma Private Limited, a active private limited company, was established on 09 December 2004 in Baddi, Himachal Pradesh, India. Engaging in pharmaceutical packaging solutions within the manufacturing sector, it holds CIN: U24230HP2004PTC027717. Registered under ROC Roc Himachal Pradesh. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹1.87 Cr.
It upholds a compliant status. Employing 232 professional, Its leadership includes Manoj Kumar Lohariwala (Director), Vinay Kumar Lohariwala (Director), Rohit Lohariwala (Director). Past directors included Manoj Kumar Lohariwala, Vinay Kumar Lohariwala, Rohit Lohariwala. It holds ₹25.20 Cr open charges and ₹6.78 Cr settled loans. Its latest AGM occurred on 25 September 2025, with the balance sheet filed on 31 March 2025. It is based at 69/A, Epip,Phase-1, Jharmajri,, Baddi, Himachal Pradesh, 173205.
U24230HP2004PTC027717
027717
09 December 2004
₹2.00 Cr
₹1.87 Cr
Roc Himachal Pradesh
Unlisted
Active
Explore comprehensive insights into Nugenic Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manoj Kumar Lohariwala | Director | 09 Dec 2004 | Current |
| Vinay Kumar Lohariwala | Director | 09 Dec 2004 | Current |
| Rohit Lohariwala | Director | 20 Mar 2014 | Current |
| Rahul Luhariwala | Director | 21 Oct 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 06 Sep 2022 | Past |
| Pramod Abcsdd | Director | 06 Sep 2022 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2015 | Past |
| Pramod Abcsdd | Additional Director | 25 Nov 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Nugenic Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 26.34% increase. The company also saw a substantial improvement in profitability, with a 467.11% increase in profit. The company's net worth moved up by a moderate rise of 4.6%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Nugenic Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹252,000,000.00
₹67,800,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Oct 2020 | Yes Bank Limited | ₹25.20 Cr | Open |
| 01 Nov 2011 | State Bank Of India | ₹4.58 Cr | Satisfied |
| 25 Feb 2011 | Axis Bank Ltd. | ₹2.20 Cr | Satisfied |
Explore comprehensive loan charge details -
Nugenic Pharma has a workforce of 232 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Nugenic Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nugenic Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Nugenic Pharma Private Limited last Annual general meeting of members was held on 25 Sep 2025 as per latest MCA records. was completed.
Nugenic Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Himachal Pradesh. was recorded as a recent event.
A charge with Yes Bank Limited of Rs. 25.20 Cr registered on 05 Oct 2020 with Charge ID 100378803 was modified on 22 Mar 2023. was recorded as a recent event.
Rahul Luhariwala was appointed as a Director was appointed as a Director on 21 Oct 2021 & has been associated with this company since 4 years 1 month . was recorded as a recent event.
Progress on A charge registered on 01 Nov 2011 via Charge ID 10320360 with State Bank Of India was fully satisfied on 20 Oct 2020. was documented.
A charge with Yes Bank Limited amounted to Rs. 25.20 Cr with Charge ID 100378803 was registered on 05 Oct 2020. was recorded as a recent event.
The CIN of Nugenic Pharma Private Limited is U24230HP2004PTC027717.
Nugenic Pharma Private Limited is headquartered at 69/A, Epip,Phase-1, Jharmajri,, Baddi, Himachal Pradesh, 173205.
Nugenic Pharma Private Limited was incorporated on 09 December 2004.
The current directors of Nugenic Pharma Private Limited are
The primary industry of Nugenic Pharma Private Limited is Manufacturing.
Nugenic Pharma Private Limited is unlisted.
The authorized capital of Nugenic Pharma Private Limited is ₹2.00 Cr, and the paid-up capital is ₹1.87 Cr.
The compliance status of Nugenic Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX